MicroRNA‑148a inhibition protects against ovariectomy‑induced osteoporosis through PI3K/AKT signaling by estrogen receptor α

The present study aimed to investigate the effect of microRNA‑148a downregulation on osteoporosis by using an ovariectomized rat model. Reverse transcription‑quantitative polymerase chain reaction was used to analyze microRNA‑148a expression levels, MTT and flow cytometry assays were used to examine cytotoxicity and Apoptosis, respectively. The gap‑associated proteins were quantified using western blotting. The expression of microRNA‑148a was significantly increased in osteoporosis rat following ovariectomy. Overexpression of microRNA‑148a significantly promoted Apoptosis and inhibited cell growth, whereas downregulation of microRNA‑148a significantly reduced Apoptosis and increased cell growth. Overexpression of microRNA‑148a significantly reduced Estrogen Receptor a (ERα) protein expression and suppressed phosphoinositide‑3‑kinase regulatory subunit 1 (PI3K) and phosphorylated‑protein kinase B (Akt) protein expression in osteoblasts in vitro. The inhibition of ERα increased the microRNA‑148a effect on Apoptosis in osteoblasts in vitro. Subsequently, LY294002, an PI3K Inhibitor, significantly increased the effect of microRNA‑148a on Apoptosis in osteoblasts in vitro. The findings of the present study revealed that anti‑microRNA‑148a protected cells against ovariectomy‑induced osteoporosis through ERα by PI3K/Akt signaling.